These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 27447883)

  • 1. Neuroprotective Effects of Paeoniflorin on 6-OHDA-Lesioned Rat Model of Parkinson's Disease.
    Gu XS; Wang F; Zhang CY; Mao CJ; Yang J; Yang YP; Liu S; Hu LF; Liu CF
    Neurochem Res; 2016 Nov; 41(11):2923-2936. PubMed ID: 27447883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASICs mediate the modulatory effect by paeoniflorin on α-synuclein autophagic degradation.
    Sun X; Cao YB; Hu LF; Yang YP; Li J; Wang F; Liu CF
    Brain Res; 2011 Jun; 1396():77-87. PubMed ID: 21529788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paeoniflorin, a potent natural compound, protects PC12 cells from MPP+ and acidic damage via autophagic pathway.
    Cao BY; Yang YP; Luo WF; Mao CJ; Han R; Sun X; Cheng J; Liu CF
    J Ethnopharmacol; 2010 Aug; 131(1):122-9. PubMed ID: 20558269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of (-)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson's disease rat models.
    Park HJ; Zhao TT; Lee KS; Lee SH; Shin KS; Park KH; Choi HS; Lee MK
    Neurochem Int; 2015; 83-84():19-27. PubMed ID: 25747493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
    Ganser C; Papazoglou A; Just L; Nikkhah G
    Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models.
    Bao XQ; Kong XC; Kong LB; Wu LY; Sun H; Zhang D
    Brain Res; 2014 Feb; 1547():49-57. PubMed ID: 24384139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of DA-9805 on dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity in the models of Parkinson's disease.
    Eo H; Kwon Y; Huh E; Sim Y; Choi JG; Jeong JS; Du XF; Soh HY; Hong SP; Kim Pak Y; Oh MS
    Biomed Pharmacother; 2019 Sep; 117():109184. PubMed ID: 31387167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF18 protects against 6-hydroxydopamine-induced nigrostriatal damage in a rat model of Parkinson's disease.
    Guo X; Liu T; Zhao D; Wang X; Liu D; He Y; Shan C; Kong Y; Hu W; Tao B; Sun L; Zhao H; Li S; Liu J
    Neuroscience; 2017 Jul; 356():229-241. PubMed ID: 28504195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paeoniflorin inhibition of 6-hydroxydopamine-induced apoptosis in PC12 cells via suppressing reactive oxygen species-mediated PKCδ/NF-κB pathway.
    Dong H; Li R; Yu C; Xu T; Zhang X; Dong M
    Neuroscience; 2015 Jan; 285():70-80. PubMed ID: 25446358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
    Chan WS; Durairajan SS; Lu JH; Wang Y; Xie LX; Kum WF; Koo I; Yung KK; Li M
    Neurochem Int; 2009 Nov; 55(6):414-22. PubMed ID: 19409437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
    Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
    Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of lentivirus-mediated cystathionine-beta-synthase overexpression against 6-OHDA-induced parkinson's disease rats.
    Yin WL; Yin WG; Huang BS; Wu LX
    Neurosci Lett; 2017 Sep; 657():45-52. PubMed ID: 28764908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humulus japonicus Prevents Dopaminergic Neuron Death in 6-Hydroxydopamine-Induced Models of Parkinson's Disease.
    Ryu YK; Kang Y; Go J; Park HY; Noh JR; Kim YH; Hwang JH; Choi DH; Han SS; Oh WK; Lee CH; Kim KS
    J Med Food; 2017 Feb; 20(2):116-123. PubMed ID: 28146406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor.
    Liu HQ; Zhang WY; Luo XT; Ye Y; Zhu XZ
    Br J Pharmacol; 2006 Jun; 148(3):314-25. PubMed ID: 16582933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferulic Acid Exerts Neuroprotective Effects via Autophagy Induction in
    Long T; Wu Q; Wei J; Tang Y; He YN; He CL; Chen X; Yu L; Yu CL; Law BY; Wu JM; Qin DL; Wu AG; Zhou XG
    Oxid Med Cell Longev; 2022; 2022():3723567. PubMed ID: 35242276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral recovery following sub-chronic paeoniflorin administration in the striatal 6-OHDA lesion rodent model of Parkinson's disease.
    Liu DZ; Zhu J; Jin DZ; Zhang LM; Ji XQ; Ye Y; Tang CP; Zhu XZ
    J Ethnopharmacol; 2007 Jun; 112(2):327-32. PubMed ID: 17451897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic protective effect of paeoniflorin and β-ecdysterone against rotenone-induced neurotoxicity in PC12 cells.
    Liu H; Yu C; Xu T; Zhang X; Dong M
    Apoptosis; 2016 Dec; 21(12):1354-1365. PubMed ID: 27688248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units.
    Zou J; Chen Z; Wei X; Chen Z; Fu Y; Yang X; Chen D; Wang R; Jenner P; Lu JH; Li M; Zhang Z; Tang B; Jin K; Wang Q
    Cell Death Dis; 2017 Jun; 8(6):e2854. PubMed ID: 28569795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.